The first bone marrow transplants (BMTs) in human patients were perfor
med after conditioning with total body irradiation (TBI). TBI remains
an important part of BMT protocols. The morbidity and mortality of BMT
remains significant, but can be decreased by the introduction of opti
mized TBI regimens. This requires dosimetric control and a detailed an
alysis and description of the physics of the TBI procedure in every BM
T center that utilizes TBI. Recommendations for such procedures are gi
ven. Radiobiological models are of help in developing less toxic TBI p
rocedures, but can only be effective after dosimetric control has been
obtained and if the influence of other variables on the outcome of BM
T are taken into account. Fractionated TBI (fraction size over 3.0 Gy
or higher) appears to be more effective and better tolerated than sing
le fraction TBI or fractionated TBI, using a small fraction size TBI.
Lung shielding is possible during TBI. Smaller organs or organs that c
annot be imaged easily are not recommended for shielding. Radiolabeled
immunoglobulins are but low molecular weight bone seeking radioisotop
es and are not expected to improve the therapeutic ratio of TBI. Other
variables in BMT are more difficult to quantify and model than TBI (e
.g. high-dose chemotherapy, graft-versus-host disease) and will be mor
e difficult to optimize.